2014
DOI: 10.1001/jamadermatol.2014.938
|View full text |Cite
|
Sign up to set email alerts
|

Dermatologic and Dental Aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements

Abstract: Skin and dental findings comprise 4 of 11 major features and 3 of 6 minor features in the diagnostic criteria. A definite diagnosis of TSC is defined as the presence of at least 2 major features or 1 major and 2 or more minor features; in addition, a pathological mutation in TSC1 or TSC2 is diagnostic. Skin and oral examinations should be performed annually and every 3 to 6 months, respectively. Intervention may be indicated for TSC skin or oral lesions that are bleeding, symptomatic, disfiguring, or negativel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
102
0
18

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 94 publications
(121 citation statements)
references
References 43 publications
1
102
0
18
Order By: Relevance
“…7 13 In patients with growing SEGA, angiomyolipoma or LAM, treatment with systemic mTOR inhibitors, which address the underlying pathophysiology of the disease, might be indicated and is also likely to result in simultaneous improvement of skin lesions. [13][14][15][16] However, systemic mTOR inhibitors can contribute to surgical complications and delayed wound healing; [17][18][19] therefore, elective procedures (eg, cutaneous surgery, laser treatment) might best be avoided while on systemic therapy. In patients not receiving systemic treatment, topical mTOR inhibitors or surgical procedures may be indicated.…”
Section: Treatment Of Tsc-associated Cutaneous Disordersmentioning
confidence: 99%
See 2 more Smart Citations
“…7 13 In patients with growing SEGA, angiomyolipoma or LAM, treatment with systemic mTOR inhibitors, which address the underlying pathophysiology of the disease, might be indicated and is also likely to result in simultaneous improvement of skin lesions. [13][14][15][16] However, systemic mTOR inhibitors can contribute to surgical complications and delayed wound healing; [17][18][19] therefore, elective procedures (eg, cutaneous surgery, laser treatment) might best be avoided while on systemic therapy. In patients not receiving systemic treatment, topical mTOR inhibitors or surgical procedures may be indicated.…”
Section: Treatment Of Tsc-associated Cutaneous Disordersmentioning
confidence: 99%
“…Erythematous lesions may respond well to pulsed-dye laser treatment, which may be enhanced by the addition of 5-aminolevulinic acid. 13 45 46 Additionally, use of ablative lasers can be helpful for fibrotic lesions, and surgical excision can be appropriate for large symptomatic lesions. 13 A range of surgical approaches has been used to treat facial angiofibromas, including dermabrasion, cryosurgery, curettage, shave excision and chemical peels.…”
Section: Non-pharmacological Therapiesmentioning
confidence: 99%
See 1 more Smart Citation
“…These macules frequently present within the first few years of life, tend to increase in number and size throughout life, but are less prominent in adults, as they become more pigmented, and may even disappear [5,7]. Therefore, in the present case was not observed hypochromic macules, probably because of the patient being adult.…”
Section: Discussionmentioning
confidence: 42%
“…Facial angiofibromas are also described in multiple endocrine neoplasia 1 and Birt-Hogg-Dubé syndrome but are less prominent features. Fibrous plaques are common and are usually unilateral forehead lesions but can occur in other areas of the face and scalp [16,19]. Multiple 1-2 mm flesh coloured mucosal fibromas occur on the oral mucosa particularly the gingivae [20].…”
Section: Clinical Featuresmentioning
confidence: 99%